CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Caplin Point Laboratories Ltd.

NSE : CAPLIPOINTEQ BSE : 524742 ISIN CODE : INE475E01026Industry : Pharmaceuticals

News

  • Caplin Point Lab. - Trading Window 27 Mar 2026 | 18:40 | Dion Global

    Caplin Point Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Re...more...

  • Caplin Point Lab. - Press Release 13 Mar 2026 | 12:03 | Dion Global

    Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 13 2026 titled Receipt of final approval b...more...

  • Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 13 Mar 2026 | 11:52 | Dion Global

    Press release regarding receipt of final approval by our subsidiary Caplin Steriles Limited from USFDA for the Potassium Phosphates Injection USPmore...

  • Caplin Point Lab. - Cessation 03 Mar 2026 | 18:47 | Dion Global

    Caplin Point Laboratories Limited has informed the Exchange regarding Cessation of Dr. C K Gariyali as Non- Executive Independent Director o...more...

  • Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Cessation 03 Mar 2026 | 18:40 | Dion Global

    Cessation of Dr. C K Gariyali as an Independent Director of the Company with effect from March 3 2026.more...

  • Caplin Point Lab. - Press Release 28 Feb 2026 | 11:58 | Dion Global

    Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 28 2026 titled Receipt of final approva...more...

  • Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 Feb 2026 | 11:45 | Dion Global

    Press Release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from USFDA for the Desmopressin Acetate Injection USPmore...

  • Caplin Point Lab. - Press Release 24 Feb 2026 | 12:40 | Dion Global

    Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 24 2026 titled Receipt of final approva...more...

  • Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 24 Feb 2026 | 12:17 | Dion Global

    Press release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from the USFDA for the Sodium Phosphates Injection USPmore...

  • Caplin Point Lab. - Analysts/Institutional Investor Meet/Con. Call Updates 11 Feb 2026 | 21:39 | Dion Global

    Caplin Point Laboratories Limited has informed the Exchange about Transcriptmore...

  • Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 11 Feb 2026 | 21:25 | Dion Global

    Transcript of the Earnings Call - Q3 - FY 2025-26more...

  • Caplin Point Lab. - Analysts/Institutional Investor Meet/Con. Call Updates 05 Feb 2026 | 21:35 | Dion Global

    Caplin Point Laboratories Limited has informed the Exchange about Link of Recordingmore...

  • Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 05 Feb 2026 | 21:30 | Dion Global

    Results - Analyst/Investor Meet - Earnings Call - Q3(2025-2026) - Audio Recordingmore...

  • Caplin Point Lab. - Investor Presentation 05 Feb 2026 | 14:40 | Dion Global

    Caplin Point Laboratories Limited has informed the Exchange about Investor Presentationmore...

  • Caplin Point Lab. Q3 net profit up 16.83% at Rs 87.28 cr 05 Feb 2026 | 14:30 | Dion Global

    The company reported standalone net profit of Rs 87.28 crore for the quarter ended December 31 2025 as compared to Rs 74.71 crore in the same period ...more...

  • Caplin Point Lab. - Announcement under Regulation 30 (LODR)-Investor Presentation 05 Feb 2026 | 14:22 | Dion Global

    Investor Presentation for the quarter and nine months ended December 31 2025more...

  • Caplin Point Lab. - Financial Results For The Quarter Ended December 31, 2025 05 Feb 2026 | 13:22 | Dion Global

    Unaudited standalone and Consolidated Financial Results for the Quarter and nine months ended December 31 2025more...

  • Caplin Point Lab. - Outcome of Board Meeting 05 Feb 2026 | 13:14 | Dion Global

    Caplin Point Laboratories Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...

  • Caplin Point Lab. - Board Meeting Outcome for Outcome Of Board Meeting 05 Feb 2026 | 13:08 | Dion Global

    Outcome of the Board Meeting held on February 05 2026more...

  • Caplin Point Lab. - Change in Director(s) 03 Feb 2026 | 15:25 | Dion Global

    Caplin Point Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex73583.22-2.25%
NSE Index22819.6-2.08%
B500DIVL503365-0.84%
BSE 1000 9759.95-2.12%
BSE 100LCTMC8455.23-2.13%
BSE Auto 53871.06-2.79%

Commodity

Gold142344-1.68%
Silver221711-5.34%
Copper1172.65187.56%
Crude Oil887838.44%
Lead195.745.61%
Mentha Oil1105.13.53%
Nickel1626.3112.06%

Currency

USD/INR 93.88(-0.01 %)
GBP/INR 125.83(0.81 %)
EUR/INR 108.74(0.47 %)
JPY/INR 0.59(0.28 %)
CAD/INR 68.24(-0.21 %)
HKD/INR 11.99(0.04 %)